Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;15(3):e70019.
doi: 10.1002/cph4.70019.

Mechanistic Insights Into Long Covid: Viral Persistence, Immune Dysregulation, and Multi-Organ Dysfunction

Affiliations
Review

Mechanistic Insights Into Long Covid: Viral Persistence, Immune Dysregulation, and Multi-Organ Dysfunction

Gautam Gupta et al. Compr Physiol. 2025 Jun.

Abstract

Long Covid is a post-viral syndrome characterized by persistent symptoms targeting multiple organ systems after initial SARS-CoV-2 infection. Current literature suggests that the mechanisms causing Long Covid involve viral persistence, immune dysregulation, systemic inflammation, endothelial dysfunction, and metabolic disturbances. By forming reservoirs in the tissues of various organs, SARS-CoV-2 may evade immunological clearances while triggering immune responses and contributing to chronic symptoms through cytokine imbalances, T-cell exhaustion, and systemic inflammation. These symptoms parallel other post-viral syndromes such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), suggesting similar mechanisms of pathology. The coronavirus has also been linked to neuroinflammation and endothelial dysfunction causing cognitive symptoms and cardiovascular complications. Furthermore, its ability to lower energy production links it to post-exertion malaise (PEM) and muscle pain. These symptoms may result from iron dysregulation and persistent oxidative stress due to Covid-impaired mitochondrial function. This review synthesizes current data on the mechanisms that drive Long Covid pathogenesis and explores potential therapeutic strategies to mitigate viral persistence, immune dysfunction, and metabolic disturbances. It is critical to understand these interactions to develop targeted interventions that address the long-term sequelae of SARS-CoV-2 infection and improve patient outcomes.

Keywords: COVID‐19; Long Covid; SARS‐CoV‐2; coronavirus; immune dysregulation; post‐acute sequelae of SARS‐CoV‐2 (PASC); viral persistence.

PubMed Disclaimer

Similar articles

Cited by

References

    1. AboTaleb, H. A., and B. S. Alghamdi. 2024. “Metformin and Fibromyalgia Pathophysiology: Current Insights and Promising Future Therapeutic Strategies.” Molecular Biology Reports 52, no. 1: 60. https://doi.org/10.1007/s11033‐024‐10159‐7.
    1. Achleitner, M., C. Steenblock, J. Dänhardt, et al. 2023. “Clinical Improvement of Long‐COVID Is Associated With Reduction in Autoantibodies, Lipids, and Inflammation Following Therapeutic Apheresis.” Molecular Psychiatry 28, no. 7: 2872–2877. https://doi.org/10.1038/s41380‐023‐02084‐1.
    1. Amani, B., and B. Amani. 2023. “Efficacy and Safety of Nirmatrelvir/Ritonavir (Paxlovid) for COVID‐19: A Rapid Review and Meta‐Analysis.” Journal of Medical Virology 95, no. 2: e28441. https://doi.org/10.1002/jmv.28441.
    1. Appelman, B., B. T. Charlton, R. P. Goulding, et al. 2024. “Muscle Abnormalities Worsen After Post‐Exertional Malaise in Long COVID.” Nature Communications 15, no. 1: 17. https://doi.org/10.1038/s41467‐023‐44432‐3.
    1. Baeza‐Flores, G. D. C., C. G. Guzmán‐Priego, L. I. Parra‐Flores, J. Murbartián, J. E. Torres‐López, and V. Granados‐Soto. 2020. “Metformin: A Prospective Alternative for the Treatment of Chronic Pain.” Frontiers in Pharmacology 11: 558474. https://doi.org/10.3389/fphar.2020.558474.